The company was founded in August 1995 and traded on the SME board of the Shenzhen Stock Exchange on May 19, 2017. We have eight dosage form production lines for hard capsules, compounds, granules, gels, tablets, syrups, alcohol, and lotion that have passed GMP certification, as well as two production lines A and B for Chinese medicine tablets. Provide patients with safe and effective products. The company is a national high-tech enterprise focusing on R&D, production and sales of new proprietary Chinese medicines. The company's main products: Kuntai capsules, bitter ginseng gel, menstrual conditioning capsules, Ningbitai capsules, hot shower tablets, Xia Kui Cao oral liquid, Huangbai capsules, cold cough capsules, Angelica oral liquid, Longzhoukou liquid, Xinlikang capsules, Xinlikang tablets. Corporate honors: Selected as “Guidelines for the Combined Diagnosis and Treatment of Menopausal Syndrome (2023 Edition)”, selected as the authoritative guide “Guidelines for the Combined Diagnosis and Treatment of Polycystic Ovarian Syndrome (2023 edition)”, the only authoritative consensus on the selection of proprietary Chinese medicines, the “Expert Consensus on Clinical Diagnosis and Treatment of Early Onset Ovarian Insufficiency (2023 Edition)”, selected as “2023H1 Top 20 Traditional Chinese Medicine Brands in Chinese Public Medical Institutions Terminal Gynecology Proprietary Chinese Medicine Brands”, “2023H1 Key City Physical Pharmacy Gynecology Proprietary Chinese Medicine Brand Top 20” and “2021 Clinical Selection” “Valuable Proprietary Chinese Medicine Brand List”, selected The “2020-2021 Chinese Home-Use Medicine List Brand” won the “2022 to 2023 Pharmacy Clerk's Most Recommended Brand”.
No Data
No Data